Osteoporosis Among Men Treated With Androgen Deprivation for Prostate Cancer

Odense University Hospital

Status and phase: Unknown; Phase 3

Conditions: Osteoporosis; Androgen Deprivation Therapy; Prostate Cancer

Treatments: Procedure: blood sampling, DXA-scan, bone scintigraphy

Study type: Interventional

Funder types: Other

Identifiers

NCT00957606

PCa & Osteoporosis 09

S-20080004

Details and patient eligibility

About

The purpose of this study is

• to determine the rate of osteoporosis among patients with advanced prostate cancer.
• to propose an algorithm for early detection of patients with advanced prostate cancer who are at risk of developing osteoporosis.

Full description

Patients with advanced prostate cancer are included at the initiating of androgen deprivation therapy.

The patients are followed for 2 years after inclusion with blood sampling, DXA-scan, questionnaire, bone scintigraphy.

Enrollment: 100 estimated patients

Sex: Male

Volunteers: No Healthy Volunteers

Inclusion criteria

• Prostate cancer
• Initiation of androgen deprivation therapy
• Oral and written informed consent

Exclusion criteria

• They withdraw their consent
• Treatment for osteoporosis within the last year
• Other malignancy
• Other bone disease, bedbound, use of steroid

Trial design

Primary purpose: Diagnostic

Allocation: Non-Randomized

Interventional model: Single Group Assignment

Masking: None (Open label)